MicroRNAs in serum and tissue can differentiate splenic hemangiosarcoma from other splenic masses in dogs
Open Access
- 19 February 2025
- journal article
- research article
- Published by SAGE Publications in Veterinary Pathology
- Vol. 62 (5) , 659-671
Abstract
Splenic masses are common in dogs and vary dramatically in their clinical behavior. Clinically, and even with histology, it can be challenging to differentiate between benign and malignant splenic masses. Hemangiosarcoma (HSA), the most common malignancy of the spleen, is a very aggressive tumor with a poor prognosis. We hypothesize that microRNAs (miRNAs) in mass tissue and serum can differentiate between HSA and other splenic masses. Fifty-nine miRNAs were investigated by reverse-transcription followed by real-time quantitative polymerase chain reaction (RT-qPCR) in serum and/or tissue from dogs with HSAs (serum n = 24 and tissue n = 17; postsplenectomy serum n = 11), lymphomas (serum n = 8 and tissue n = 11), nonangiomatous nonlymphomatous sarcomas (serum n = 6 and tissue n = 10), histiocytic sarcomas (tissue n = 4), benign splenic masses (myelolipomas, nodular hyperplasia, and hematomas; total serum n = 21 and total tissue n = 35), and normal dogs (serum n = 14 and tissue n = 7). Numerous miRNAs were differentially expressed in serum and tissue of HSA cases compared to those with other splenic masses or normal spleens. In serum, our 5-miRNA model (miR-135a-5p, miR-10a, miR-450b, miR-152-3p, and miR-126-5p) accurately classified 100% (24/24) of dogs with HSA from normal dogs and those with a benign splenic mass (recall = 1 for HSA). The overall accuracy of the model was 86%. In HSA and benign splenic mass tissues, our 3-miRNA model (miR-126-5p, miR-502-3p, and miR-452-5p) accurately classified 96% of the cases. This study demonstrates the utility of miRNA models in serum and tissue for screening and diagnosis of HSA in dogs. Future studies include the evaluation of prospective and prediagnosis serum samples.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2020-06472)
- Natural Sciences and Engineering Research Council of Canada (Vanier Canadian Graduate Scholarship)
- Ontario Veterinary College, University of Guelph (OVC Fellowship)
- OVC Pet Trust (055849)
This publication has 37 references indexed in Scilit:
- Refining the “double two‐thirds” rule: Genotype‐based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogsVeterinary and Comparative Oncology, 2020
- Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic diseaseScientific Reports, 2017
- Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic reviewInternational Journal of Clinical Oncology, 2017
- An overview of microRNAsAdvanced Drug Delivery Reviews, 2015
- MicroRNA profiling: approaches and considerationsNature Reviews Genetics, 2012
- Extracellular microRNA: A new source of biomarkersMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2011
- Concentration of Lipocalin Region of Collagen XXVII Alpha 1 in the Serum of Dogs with HemangiosarcomaJournal of Veterinary Internal Medicine, 2011
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple TestingJournal of the Royal Statistical Society Series B: Statistical Methodology, 1995
- Hemostatic Abnormalities in Dogs With HemangiosarcomaJournal of Veterinary Internal Medicine, 1991